Related Experiment Video
Updated: Jul 10, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
Prognostic Factors for Hyperglycemia in Patients Receiving Chemotherapy
1Author Affiliations: College of Nursing (Ms Kim) and Department of Nursing (Dr Lim), Keimyung University, Daegu, South Korea.
Cancer Nursing
|November 22, 2023
Summary
Hyperglycemia in cancer patients undergoing chemotherapy is influenced by factors like sex, education, exercise, and diet. Incorporating these prognostic factors into nursing interventions can improve chemotherapy outcomes.
Area of Science:
- Oncology
- Clinical Nursing
- Metabolic Disorders
Background:
- Hyperglycemia affects 10-30% of chemotherapy patients, impacting treatment efficacy and adverse reactions.
- Limited research exists on hyperglycemia predictors and their integration into nursing care.
- Understanding these factors is crucial for optimizing cancer patient management.
Purpose of the Study:
- To identify prognostic factors associated with hyperglycemia in cancer patients receiving chemotherapy.
- To provide evidence for developing targeted nursing interventions.
Main Methods:
- Retrospective descriptive study of 134 adult cancer patients undergoing chemotherapy.
- Data collected from July 2021 to March 2022.
- Statistical analysis included frequency, t-tests, chi-squared tests, and logistic regression.
Main Results:
- Male sex, lower education levels, and specific exercise durations (30-90 minutes, ≥90 minutes) were linked to higher hyperglycemia risk.
- Higher weekly calorie expenditure from exercise (≥2000 kcal/wk) was associated with lower risk.
- Increased daily intake of fat and protein, and seaweed consumption showed significant associations with hyperglycemia.
Conclusions:
- Prognostic factors such as exercise, diet (fat, protein, seaweed), sex, and education level are key predictors of hyperglycemia in chemotherapy patients.
- Individualized nursing interventions focusing on diet and exercise are recommended, especially for high-risk groups (men, low education).
- Integrating these findings into nursing practice can help manage hyperglycemia, reduce chemotherapy side effects, and improve treatment outcomes.
Related Concept Videos
01:15Hypoglycemia and Glucagon
273
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
273
01:15Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
210
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
210
01:22Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
01:15Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
01:19Psychoneuroimmunology: Diabetes and Cancer
30
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
30